Dow Down0.68% Nasdaq Down0.42%

Neurocrine Biosciences Inc. (NBIX)

15.10 Down 0.46(2.96%) 4:15PM EDT
|After Hours : 15.10 0.00 (0.00%) 4:46PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.9
Mean Recommendation (last week):1.9

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:22.67
Median Target:22.50
High Target:26.00
Low Target:20.00
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 19, 2013OppenheimerInitiated Outperform
Mar 16, 2012Deutsche BankInitiated Buy
Aug 9, 2011MKM PartnersInitiated Buy
Mar 12, 2010Piper JaffrayInitiated Neutral
Oct 30, 2008Piper JaffrayUpgradeSellNeutral
Dec 14, 2007Bear StearnsDowngradePeer PerformUnderperform
Oct 11, 2007WachoviaInitiated Mkt Perform
Jan 17, 2007Lehman BrothersUpgradeEqual-weightOverweight
Jan 5, 2007UBSUpgradeReduceNeutral
Nov 16, 2006Bear StearnsUpgradeUnderperformPeer Perform

More Upgrades & Downgrades for NBIX

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1123

Data provided by Thomson/First Call

Currency in USD.